P. Weidmann

发表

Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renin.

S. Massry, P. Weidmann, C. Beretta-Piccoli, 1977, Annals of internal medicine.

Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients.

P. Weidmann, M. D. de Courten, L. Böhlen, 1994, American journal of hypertension.

Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.

P. Weidmann, L. Böhlen, W. Riesen, 1996, Journal of cardiovascular pharmacology.

Insulin sensitivity in humans: alterations during drug administration and in essential hypertension.

P. Weidmann, P. Ferrari, 1990, Mineral and electrolyte metabolism.

Requirements for antihypertensive therapy in diabetic patients: metabolic aspects

P. Weidmann, A. Teuscher, 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Effects of Calcium Antagonists on Glucose Homeostasis and Serum Lipids in Non-Diabetic and Diabetic Subjects: A Review

P. Weidmann, B. Trost, 1987, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Pressor Factors and Responsiveness in Hypertension Accompanying Diabetes Mellitus

P. Weidmann, C. Beretta-Piccoli, B. Trost, 1985, Hypertension.

Hypertension in terminal renal failure.

P. Weidmann, C. Beretta-Piccoli, F. Reubi, 1976, Kidney international.

Plasma prolactin in normal and hypertensive subjects: relationships with age, posture, blood pressure, catecholamines, and renin.

P. Weidmann, U. Hennes, W. Ziegler, 1980, The Journal of clinical endocrinology and metabolism.

Calcium Antagonists in Patients with Hypertension and Diabetes Mellitus

P. Weidmann, B. Trost, 1986 .

Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics.

T. Lüscher, G. Noll, P. Weidmann, 1997, Journal of the American College of Cardiology.

Association between sympathetic activity and the atherogenic serum cholesterol fraction

P. Weidmann, C. Beretta-Piccoli, W. Riesen, 1990, Klinische Wochenschrift.

Serum Lipoproteins During Treatment with the Antihypertensive Agent Indapamide

P. Weidmann, K. Laederach, W. Riesen, 1985, Hypertension.

Effects of antihypertensive therapy on serum lipoproteins.

P. Weidmann, R. Mordasini, A. Gerber, 1983, Hypertension.

Effects of indapamide and various diuretics alone or combined with beta-blockers on serum lipoproteins.

P. Weidmann, M. Bianchetti, R. Mordasini, 1983, Current medical research and opinion.

Reversal or prevention of diuretic-induced alterations in serum lipoproteins with betablockers.

P. Weidmann, W. Riesen, C. Bachmann, 1982, Atherosclerosis.

Increased ratio between serum beta- and alpha-lipoproteins during diuretic therapy: an adverse effect?

P. Weidmann, J. Flammer, C. Bachmann, 1978, Clinical science and molecular medicine. Supplement.

Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone.

P. Weidmann, W. Riesen, C. Bachmann, 1980, Metabolism: clinical and experimental.

Antihypertensive treatment and serum lipoproteins.

P. Weidmann, D. Uehlinger, A. Gerber, 1985, Journal of hypertension.

Menopause-dependent plasma lipoprotein alterations in diuretic-treated women.

P. Weidmann, W. Riesen, H. Schiffl, 1982, Annals of internal medicine.

Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent.

P. Weidmann, D. Giachino, W. Riesen, 1991, The American journal of medicine.

Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension.

P. Weidmann, D. Hutter, Y. Allemann, 2001, American journal of hypertension.

Central Role of Sodium in Hypertension in Diabetic Subjects

P. Weidmann, P. Ferrari, 1991, Diabetes Care.

The Pathogenesis of Hypertension in Obese Subjects

P. Weidmann, M. Courten, S. Shaw, 2012, Drugs.

Increased central body fat deposition precedes a significant rise in resting blood pressure in male offspring of essential hypertensive parents: a 5 year follow-up study

P. Weidmann, D. Hutter, Y. Allemann, 2001, Journal of hypertension.

Treatment of elevated blood pressure in diabetic patients.

P. Weidmann, L. Böhlen, A. Teuscher, 1997, Journal of diabetes and its complications.

Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.

P. Weidmann, D. Wohler, B. Waeber, 1996, American journal of hypertension.

Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis.

P. Weidmann, L. Böhlen, M. Schneider, 1995, Nephrology, Dialysis and Transplantation.

[Improved glucose regulation and microalbuminuria/proteinuria in diabetic patients treated with ACE inhibitors. A meta-analysis of published studies of 1985-1990].

R. Bergemann, P. Weidmann, J. Betzin, 1992, Schweizerische medizinische Wochenschrift.

Atrial natriuretic peptide protects against acute ischemic renal failure in the rat.

J. Hodler, P. Weidmann, S. Shaw, 1987, Journal of Clinical Investigation.

Blunted aldosterone responsiveness to angiotensin II in normotensive subjects with familial predisposition to essential hypertension.

P. Weidmann, P. Städler, C. Beretta‐Piccoli, 1988, Journal of hypertension.

Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension.

P. Weidmann, F. Reubi, W. Ziegler, 1978, Kidney international.

Plasma catecholamines and cardiovascular response in mild renal failure.

P. Weidmann, F. Reubi, H. Schiffl, 1984, Contributions to nephrology.

Pathogenesis of hypertension associated with chronic renal failure.

P. Weidmann, 1984, Contributions to nephrology.

Antihypertensive Therapy With Ca2+: Antagonist Verapamil and/or ACE Inhibitor Enalapril in NIDDM Patients

P. Weidmann, W. Riesen, U. Keller, 1991, Diabetes Care.

Plasma renin activity and blood pressure in terminal renal failure.

S. Massry, P. Weidmann, M. Maxwell, 1971, The New England journal of medicine.

Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease.

S. Massry, P. Weidmann, M. Maxwell, 1973, The Journal of clinical endocrinology and metabolism.

The Use of Centrally Acting Antihypertensuve Drugs in Patients with Renal Disease

P. Weidmann, Caroline Baray, 2015 .

Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus

P. Weidmann, 1980, Klinische Wochenschrift.

Relation of arterial pressure with exchangeable and total body sodium and with plasma exchangeable and total body potassium in essential hypertension.

J. Brown, P. Weidmann, P. Padfield, 1981, Clinical science.

Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus.

P. Weidmann, F. Reubi, J. Flammer, 1977, Kidney international.

Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension.

P. Weidmann, F. Reubi, C. Beretta‐Piccoli, 1976, The American journal of medicine.

Hypertension in chronic renal failure.

P. Weidmann, F. Reubi, J. Tuckman, 1974, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin.

Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects

P. Weidmann, M. Bianchetti, A. Meier, 1982, Klinische Wochenschrift.

Renin-hyporesponsiveness in essential hypertension dissociation between plasma renin and catecholamines or aldosterone following furosemide

P. Weidmann, W. Ziegler, A. Meier, 1980, Klinische Wochenschrift.

Pathogenesis of hypertension accompanying diabetes mellitus.

P. Weidmann, 1989, Contributions to nephrology.

Effects of standard oral glucose loading on the renin-angiotensin-aldosterone system and its relationship to circulating insulin

P. Weidmann, J. Flammer, C. Bachmann, 1980, Klinische Wochenschrift.

Effect of oral glucose loading on plasma insulin, potassium, renin and aldosterone in normal subjects and patients with primary hyperaldosteronism.

J. Brown, P. Weidmann, A. Lever, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Insulin, insulin sensitivity and hypertension.

P. Weidmann, P. Ferrari, Peter Weidmann, 1990, Journal of hypertension.

Total plasma clearance of infused norepinephrine in non-azotemic diabetes mellitus

P. Weidmann, C. Beretta‐Piccoli, 1982, Klinische Wochenschrift.

Effects of Short‐Term Norepinephrine Infusion on Plasma Catecholamines, Renin, and Aldosterone in Normal and Hypertensive Man

P. Weidmann, A. Meier, G. Keusch, 1980, Hypertension.

Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents

F. Horber, P. Jaeger, P. Weidmann, 1993, The Lancet.

Antihypertensive agents, serum lipoproteins and glucose metabolism.

P. Weidmann, P. Ferrari, J. Rosman, 1991, The American journal of cardiology.

Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents.

P. Weidmann, A. Teuscher, S. Shaw, 1998, Journal of cardiovascular pharmacology.

Hypoaldosteronism without hyperkalemia

P. Weidmann, F. Reubi, Z. Glück, 1980, Klinische Wochenschrift.

Responses of catecholamines and blood pressure to beta-blockade in diuretic-treated patients with essential hypertension

P. Weidmann, W. Ziegler, A. Meier, 1982, Klinische Wochenschrift.

P. Weidmann, A. Meier, Z. Glück, 1980, Klinische Wochenschrift.

Catecholamines, renin, aldosterone, and blood volume during chronic minoxidil therapy

P. Weidmann, W. Ziegler, A. Meier, 1981, Klinische Wochenschrift.

Interrelationships between sodium clearance, plasma aldosterone, plasma renin activity, renal hemodynamics and blood pressure in renal disease

P. Weidmann, F. Reubi, Z. Glück, 1979, Klinische Wochenschrift.

Plasma catecholamines and renin in diabetes mellitus

P. Weidmann, W. Ziegler, Z. Glück, 1979, Klinische Wochenschrift.

Studies on acute glucose-induced aldosterone suppression: Role of renin-angiotensin system

P. Weidmann, C. Ferrier, A. Gerber, 1984, Klinische Wochenschrift.

Interrelations between age and plasma renin, aldosterone and cortisol, urinary catecholamines, and the body sodium/volume state in normal man

P. Weidmann, F. Reubi, W. Vetter, 1977, Klinische Wochenschrift.

Effects of the dopaminergic agonist cianergoline on blood pressure, the renin-angiotensin-aldosterone axis and the sympathetic nervous system in patients with essential hypertension

P. Weidmann, W. Ziegler, C. Foletti, 2004, European Journal of Clinical Pharmacology.

Cardiovascular regulation and lipoprotein profile during administration of co-dergocrine in essential hypertension

P. Weidmann, D. Uehlinger, M. P. Gnaedinger, 2004, European Journal of Clinical Pharmacology.

Plasma insulin during physiological and pathophysiological changes in atrial natriuretic factor

P. Weidmann, W. Riesen, P. Ferrari, 1992, European Journal of Clinical Pharmacology.

Chronic treatment with the new potent vasodilator Ro 12-4713 in moderate to severe hypertension: Effects on blood pressure, endocrine function, sodium and plasma volume

P. Weidmann, W. Ziegler, H. Schiffl, 2004, European Journal of Clinical Pharmacology.

Stimulation of renin secretion by potassium-channel activation with cromakalim

P. Weidmann, A. Kurtz, S. Shaw, 2004, European Journal of Clinical Pharmacology.

Cardiovascular regulation during administration of co-dergocrine to normal subjects

P. Weidmann, K. Laederach, A. Gerber, 2004, European Journal of Clinical Pharmacology.

Acute effects of a new vasodilator, Ro 12-4713, on blood pressure, plasma renin activity, aldosterone and catecholamine levels, and renal function in hypertensive and normal subjects

P. Weidmann, F. Reubi, W. Ziegler, 2004, European Journal of Clinical Pharmacology.

Antihypertensive mechanism of the diuretic muzolimine in mild renal failure

P. Weidmann, W. Ziegler, H. Schiffl, 1982, European Journal of Clinical Pharmacology.

Acute sodium loading in patients with uncomplicated diabetes mellitus: renal and hormonal effects.

D. Cusi, P. Weidmann, S. Shaw, 1994, Clinical science.

Short communications Plasma insulin during physiological and pathophysiological changes in atrial natriuretic factor

P. Weidmann, W. Riesen, P. Ferrari, 1992 .

Enhanced blood pressure response to mineralocorticoid stimulation in normotensive members of hypertensive families.

P. Weidmann, Y. Allemann, P. Ferrari, 1992, Blood pressure.

Cardiovascular pressor reactivity after chronic converting enzyme inhibition.

P. Weidmann, C. Marone, S. Shaw, 1991, American journal of hypertension.

Dysregulation of atrial natriuretic factor in hypertension-prone man.

P. Weidmann, P. Ferrari, S. Shaw, 1990, The Journal of clinical endocrinology and metabolism.

Calcitonin gene-related peptide is a stimulator of renin secretion.

T. Hökfelt, P. Weidmann, A. Kurtz, 1988, The Journal of clinical investigation.

Glucocorticoid and mineralocorticoid stimulation of atrial natriuretic peptide release in man.

P. Weidmann, C. Hess, D. Uehlinger, 1988, The Journal of clinical endocrinology and metabolism.

Atrial natriuretic factor in mild to moderate chronic renal failure.

P. Weidmann, S. Shaw, C. Ferrier, 1988, Hypertension.

Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.

P. Weidmann, E. Peheim, M. Gnädinger, 1987, Hypertension.

Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension.

P. Weidmann, C. Ferrier, C. Beretta‐Piccoli, 1986, Hypertension.

Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man.

P. Weidmann, D. Uehlinger, R. Lang, 1986, The Journal of clinical endocrinology and metabolism.

Body sodium-blood volume state, aldosterone, and cardiovascular responsiveness after calcium entry blockade with nifedipine.

P. Weidmann, F. Bomio, C. Marone, 1985, Kidney international.

Cardiovascular and metabolic profile during intervention with urapidil in humans.

P. Weidmann, W. Riesen, C. Marone, 1985, Hypertension.

Relationship between plasma aldosterone and angiotensin II before and after noradrenergic inhibition in normal subjects and patients with mild essential hypertension.

P. Weidmann, J. Morton, M. Bianchetti, 1984, The Journal of clinical endocrinology and metabolism.

Increased serum high-density lipoprotein cholesterol in hypertensive men treated with the potent vasodilator carprazidil.

P. Weidmann, W. Riesen, R. Zbinden, 1984, Metabolism: clinical and experimental.

Cardiovascular counterregulation during sympathetic inhibition in normal subjects and patients with mild hypertension.

P. Weidmann, J. Morton, M. Bianchetti, 1983, Hypertension.

Antihypertensive mechanism of diuretic treatment with chlorthalidone. Complementary roles of sympathetic axis and sodium.

P. Weidmann, W. Ziegler, A. Meier, 1983, Kidney international.

Constant kinetics and constant concentration‐effect relationship during long‐term β3‐blockade with pindolol

P. Weidmann, M. Pirovino, R. Galeazzi, 1983, Clinical pharmacology and therapeutics.

Calcium and blood pressure regulation in normal and hypertensive subjects.

P. Weidmann, J. Morton, M. Bianchetti, 1983, Hypertension.

Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.

P. Weidmann, F. Reubi, H. Schiffl, 1983, British journal of clinical pharmacology.

Responsiveness of plasma 18-Hydroxycorticosterone and Aldosterone to Angiotensin II or Corticotropin in Nonazotemic Diabetes Mellitus

P. Weidmann, R. Fraser, C. Beretta‐Piccoli, 1983, Diabetes.

Correction of altered noradrenaline reactivity in essential hypertension by indapamide.

P. Weidmann, W. Ziegler, A. Meier, 1983, Current medical research and opinion.

Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease.

P. Weidmann, F. Reubi, H. Schiffl, 1982, Kidney international.

Studies on aldosterone responsiveness to angiotensin II during clinical variations in calcium metabolism in normal man.

P. Weidmann, J. Morton, M. Bianchetti, 1982, Clinical science.

Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the betablocker pindolol.

P. Weidmann, W. Riesen, H. Schiffl, 1982, Metabolism: clinical and experimental.

Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus.

P. Weidmann, C. Beretta‐Piccoli, 1981, The American journal of medicine.

Responsiveness of plasma renin and aldosterone in diabetes mellitus.

P. Weidmann, G. Keusch, C. Beretta‐Piccoli, 1981, Kidney international.

Acute hypercalcemic hypertension in man: role of hemodynamics, catecholamines, and renin.

P. Weidmann, C. Marone, C. Beretta‐Piccoli, 1981, Kidney international.

Pressor Factors and Cardiovascular Pressor Responsiveness in Borderline Hypertension

P. Weidmann, W. Ziegler, A. Meier, 1981, Hypertension.

Correction of altered noradrenaline reactivity in essential hypertension by indapamide.

P. Weidmann, W. Ziegler, A. Meier, 1981, British heart journal.

Role of haemodynamics, catecholamines and renin in acute hypercalcaemic hypertension in man.

P. Weidmann, C. Marone, C. Beretta‐Piccoli, 1980, Clinical science.

Relationships between sodium clearance, plasma renin activity, plasma aldosterone, renal hemodynamics and blood pressure in essential hypertension.

P. Weidmann, F. Reubi, 1980, Clinical and experimental hypertension.

Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension.

V. Campese, S. Massry, P. Weidmann, 1980, Kidney international.

beta blockade with pindolol: differential cardiac and renal effects despite similar plasma kinetics in normal and uremic man.

P. Weidmann, M. Gugger, R. Galeazzi, 1979, Kidney international.

Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus.

P. Weidmann, W. Ziegler, A. Meier, 1979, The American journal of medicine.

Cardiovascular and endocrine profile of adrenergic neurone blockade in normal and hypertensive man.

P. Weidmann, F. Reubi, J. Flammer, 1979, The American journal of medicine.

Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion.

P. Weidmann, F. Reubi, J. Flammer, 1978, The American journal of cardiology.

Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2.

P. Weidmann, A. Teuscher, P. Gerber, 1999, Journal of cardiovascular pharmacology.

Diabetes and Hypertension

F. Gries, P. Weidmann, 1988, Springer Berlin Heidelberg.

Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension

P. Weidmann, F. Reubi, W. Ziegler, 1980, Klinische Wochenschrift.

Insulin resistance and hyperinsulinemia in hypertension

P. Weidmann, L. Böhlen, Maximilian de Coyrten, 1995, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Effect of diuretics on the plasma lipid profile.

P. Weidmann, M. D. de Courten, P. Ferrari, 1992, European heart journal.

Swiss Hypertension Treatment Programme with Verapamil and/or Enalapril in Diabetic Patients

P. Weidmann, W. Riesen, P. Ferrari, 2012, Drugs.

Serum Lipoproteins During Treatment with Antihypertensive Drugs

P. Weidmann, M. D. de Courten, L. Böhlen, 1993, Journal of cardiovascular pharmacology.

Endothelin‐1 infusion inhibits plasma insulin responsiveness in normal men

G. Pacini, P. Weidmann, A. Teuscher, 1998, Journal of hypertension.

Serum Lipoproteins During Treatment with Antihypertensive Drugs

P. Weidmann, D. Uehlinger, C. Ferrier, 2012, Drugs.

Antihypertensive and hypouricaemic effects of nitrendipine in chronic renal failure

P. Weidmann, W. Riesen, D. Schohn, 2004, European Journal of Clinical Pharmacology.

Lasting Improvement of Renovascular Hypertension by Transluminal Dilatation of Atherosclerotic and Nonatherosclerotic Renal Artery Stenoses: A Follow‐up Study

P. Weidmann, P. Probst, F. Mahler, 1982, Circulation.

Cardiovascular Pressor Reactivity as Related to Plasma Catecholamines: Role in the Pathogenesis of Essential Hypertension and in the Antihypertensive Mechanism of Diuretic Treatment

P. Weidmann, A. Meier, Z. Glück, 1980 .

Control of aldosterone responsiveness in terminal renal failure.

P. Weidmann, D. Hirsch, M. Maxwell, 1975, Kidney international.

Plasma renin and blood pressure during treatment with methyldopa.

P. Weidmann, D. Hirsch, M. Maxwell, 1974, The American journal of cardiology.

Atrial Natriuretic Peptide: Protective Effects in Acute Renal Failure

P. Weidmann, S. Shaw, 1989 .

Effects of posture and ageing on circulating atrial natriuretic peptide levels in man.

P. Weidmann, D. Uehlinger, B. Haller, 1987, Journal of hypertension.

[Secondary hyperlipoproteinemia induced by diuretic therapy (author's transl)].

P. Weidmann, W. Riesen, R. Mordasini, 1980, Klinische Wochenschrift.

Treatment of the Hypertensive Diabetic: Focus on Calcium Channel Blockade

P. Weidmann, P. Ferrari, B. Trost, 1989 .

Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension.

P. Weidmann, F. Reubi, W. Rascher, 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Pathogenetic and therapeutic relevance of cardiovascular pressor reactivity to norepinephrine in human hypertension.

P. Weidmann, 1989, Clinical and experimental hypertension. Part A, Theory and practice.

INHIBITION OF RAT GLOMERULAR MESANGIAL CELL SODIUM/HYDROGEN EXCHANGE BY HYDROGEN PEROXIDE

P. Weidmann, S. Shaw, P. Naegeli, 1995, Clinical and experimental pharmacology & physiology.

Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease.

S. Massry, P. Weidmann, M. Maxwell, 1975, Nephron.

Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II

G. Noseda, P. Weidmann, W. Riesen, 2004, European Journal of Clinical Pharmacology.

Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man.

P. Weidmann, D. Uehlinger, R. Lang, 1986, The Journal of clinical endocrinology and metabolism.

Increase in Circulating Insulin Induced by Atrial Natriuretic Peptide in Normal Humans

P. Weidmann, D. Uehlinger, R. Lang, 1986, Journal of cardiovascular pharmacology.

Pathogenesis and treatment of hypertension associated with diabetes.

P. Weidmann, B. Trost, 1985, Hormone and metabolic research. Supplement series.

Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure.

P. Weidmann, C. Hess, D. Uehlinger, 1987, Kidney international.

Effects of different antihypertensive drugs on human diabetic proteinuria.

P. Weidmann, M. D. de Courten, L. Boehlen, 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Calcium Channel Blockers in the Treatment of Hypertension

P. Weidmann, D. Uehlinger, M. P. Gnaedinger, 1986 .

Insulin resistance, hyperinsulinemia and hypertension

P. Weidmann, M. D. de Courten, L. Böhlen, 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Plasma arginine-vasopressin levels during infusion of synthetic atrial natriuretic peptide on different sodium intakes in man.

P. Weidmann, W. Rascher, D. Uehlinger, 1986, Journal of hypertension.

[Correlations between blood pressure, blood volume, plasma renin and urinary catecholamines in normal subjects and in patients with benign essential hypertension].

P. Weidmann, D. Hirsch, F. Reubi, 1976, Schweizerische medizinische Wochenschrift.

Left ventricular structure and determinants in normotensive offspring of essential hypertensive parents

P. Weidmann, Y. Allemann, P. Ferrari, 1992, Journal of hypertension.

Calcium antagonists in the treatment of hypertension: a critical overview.

P. Weidmann, K. Laederach, A. Gerber, 1985, Advances in nephrology from the Necker Hospital.

Beta-receptor-blocking agents may reverse or prevent diuretic-induced increases in serum low-density lipoprotein cholesterol.

P. Weidmann, W. Riesen, H. Schiffl, 1981, Clinical science.

Body sodium-blood volume state in nonazotemic diabetes mellitus.

P. Weidmann, C. Beretta‐Piccoli, 1982, Mineral and electrolyte metabolism.

Distinct hemodynamic and renal effects of calcitonin gene-related peptide and calcitonin in men.

P. Weidmann, W. Rascher, D. Uehlinger, 1989, The American journal of physiology.

Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans.

P. Weidmann, J. Morton, M. Bianchetti, 1982, Journal of cardiovascular pharmacology.

Effects of human atrial natriuretic peptide on the pressor action of noradrenaline and angiotensin II in normal subjects.

P. Weidmann, D. Uehlinger, S. Shaw, 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Atrial natriuretic peptide in man.

P. Weidmann, S. Shaw, C. Ferrier, 1989, Journal of steroid biochemistry.

Atrial natriuretic peptide in man.

P. Weidmann, S. Shaw, C. Ferrier, 1988, American journal of nephrology.

Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension.

B. W. East, J. Brown, P. Weidmann, 1982, Clinical science.

Plasma and urinary catecholamines as related to renal function in man.

P. Weidmann, K. Laederach, 1987, Kidney international.

Body-sodium and blood volume in a patient with licorice-induced hypertension.

P. Weidmann, C. Beretta‐Piccoli, G. Salvadé, 1985, Journal of hypertension.

Insulin Sensitivity and Atrial Natriuretic Factor During β‐Receptor Modulation with Celiprolol in Normal Subjects

F. Hafezi, P. Weidmann, M. D. de Courten, 1994, Journal of cardiovascular pharmacology.

Atrial natriuretic factor increases in response to an acute glucose load

P. Weidmann, L. Böhlen, Y. Allemann, 1994, Journal of hypertension.

patients with essential hypertension

P. Weidmann, W. Ziegler, G. Keusch, 1978 .

Renal handling of norepinephrine and epinephrine in the pig

P. Weidmann, P. Probst, L. Link, 1985, Pflügers Archiv.

Complications in percutaneous transluminal dilatation of renal arteries.

P. Weidmann, F. Mahler, B. Nachbur, 1986, Nephron.

Body Sodium Blood Volume State in Essential Hypertension: Abnormal Relation of Exchangeable Sodium to Age and Blood Pressure in Male Patients

J. Brown, P. Weidmann, D. Davies, 1984, Journal of cardiovascular pharmacology.

Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.

P. Weidmann, W. Riesen, F. Nelemans, 1987, The American journal of cardiology.

Urodilatin, not nitroprusside, combined with dopamine reverses ischemic acute renal failure.

P. Weidmann, S. Shaw, A. Zimmermann, 1992, Kidney international.

Pathogenic and therapeutic significance of cardiovascular pressor reactivity as related to plasma catecholamines in borderline and established essential hypertension.

P. Weidmann, A. Meier, Z. Glück, 1980, Clinical and experimental hypertension.

Responsiveness of plasma aldosterone: Dependency upon basal secretory activity

F. Messerli, P. Weidmann, M. Maxwell, 1978, Klinische Wochenschrift.

Acute Renal Failure Following Intravenous Use of Radiographic Contrast Dyes in Patients with Diabetes Mellitus

S. Massry, P. Weidmann, D. Makoff, 1977, Diabetes.

Plasma kinetics of synthetic alpha-human atrial natriuretic peptide in man.

P. Weidmann, D. Uehlinger, R. Lang, 1986, Mineral and electrolyte metabolism.

[Plasma renin activity in pheochromocytoma].

P. Weidmann, C. Werning, W. Siegenthaler, 1970, Deutsche medizinische Wochenschrift.

Catecholamines and their possible role in hypertension associated with impaired renal function.

P. Weidmann, K. Laederach, D. Uehlinger, 1987, Contributions to nephrology.

Minoxidil therapy in refractory hypertension analysis of 155 patients.

V. Campese, S. Massry, P. Weidmann, 1978, Nephron.

ROLE OF INTRACELLULAR SIGNALLING PATHWAYS IN HYDROGEN PEROXIDE‐INDUCED INJURY TO RAT GLOMERULAR MESANGIAL CELLS

P. Weidmann, S. Shaw, S. Shaw, 1995, Clinical and experimental pharmacology & physiology.

Atrial natriuretic peptide in acute mountain sickness.

P. Weidmann, P. Bärtsch, S. Shaw, 1988, Journal of applied physiology.

EFFECT OF A NEW SOMATOSTATIN ANALOGUE SMS 201‐995 (SANDOSTATIN) ON THE RENIN‐ALDOSTERONE AXIS

P. Weidmann, E. Pozo, S. Shaw, 1988, Clinical endocrinology.

[Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study].

P. Erne, G. Noseda, P. Weidmann, 1993, Schweizerische medizinische Wochenschrift.

Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.

P. Weidmann, S. Shaw, C. Ferrier, 1989, American journal of nephrology.

Impaired response of atrial natriuretic factor to high salt intake in persons prone to hypertension.

P. Weidmann, C. Ferrier, R. Dietler, 1988, The New England journal of medicine.

Renal response to low-dose infusion of atrial natriuretic peptide in normal man.

P. Weidmann, M. Gnädinger, C. Cottier, 1988, Kidney international. Supplement.

infusion in humans Pressure dependence of atrial natriuretic peptide during norepinephrine

P. Weidmann, D. Uehlinger, M. Gnädinger, 2011 .

Pressure dependence of atrial natriuretic peptide during norepinephrine infusion in humans.

P. Weidmann, D. Uehlinger, S. Shaw, 1987, Hypertension.

Increased ratio between changes in blood pressure and plasma norepinephrine in essential hypertension.

P. Weidmann, F. Reubi, J. Flammer, 1979, The Journal of clinical endocrinology and metabolism.

Plasma aldosterone in terminal renal failure.

P. Weidmann, M. Maxwell, A. Lupu, 1973, Annals of internal medicine.

Normotensive offspring of hypertensive parents: no evidence of left ventricular diastolic dysfunction in a cross-sectional study.

P. Weidmann, Y. Allemann, B. Aeschbacher, 1998, Blood pressure.

Transluminal dilatation of renal artery stenoses due to atherosclerosis and fibromuscular dysplasia : early results and follow-up of twelve consecutive cases.

P. Weidmann, P. Probst, F. Mahler, 1981, Annales de radiologie.

Cardiovascular, metabolic and hormonal dysregulations in normotensive offspring of essential hypertensive parents.

P. Weidmann, Y. Allemann, 1995, Journal of hypertension.

Developing essential hypertension: a syndrome involving ANF deficiency?

P. Weidmann, Y. Allemann, P. Ferrari, 1991, Canadian journal of physiology and pharmacology.

Serum lipoproteins in patients with mild renal disease treated with the diuretic muzolimine

P. Weidmann, W. Riesen, H. Schiffl, 1982, Klinische Wochenschrift.

Effects of Nitrendipine and Other Calcium Antagonists on Glucose Metabolism in Man

P. Weidmann, B. Trost, 1984, Journal of cardiovascular pharmacology.

Dysregulation of Blood Pressure in Normotensive Offspring of Hypertensive Parents

P. Weidmann, C. Beretta‐Piccoli, 1988, Journal of cardiovascular pharmacology.

Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol.

P. Weidmann, S. Shaw, C. Ferrier, 1991, Journal of hypertension.

Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure.

S. Massry, P. Weidmann, C. Kleeman, 1972, Annals of internal medicine.

Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men.

P. Weidmann, W. Forssmann, A. Bub, 1990, The American journal of physiology.

[On the diagnosis of Conn's syndrome].

P. Weidmann, W. Siegenthaler, J. Möhring, 1967, Deutsche medizinische Wochenschrift.

[Single-needle hemodialysis].

P. Weidmann, C. Descoeudres, C. Beretta‐Piccoli, 1975, Schweizerische medizinische Wochenschrift.

Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension

P. Weidmann, W. Ziegler, H. Schiffl, 1982, European Journal of Clinical Pharmacology.

Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients

P. Weidmann, L. Böhlen, W. Riesen, 2004, European Journal of Clinical Pharmacology.

Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension

P. Weidmann, L. Böhlen, W. Riesen, 2004, European Journal of Clinical Pharmacology.

Metabolic Profile of Indapamide Sustained-Release in Patients with Hypertension

P. Weidmann, 2001, Drug safety.

Pathogenesis and treatment of hypertension associated with diabetes mellitus.

P. Weidmann, M. D. de Courten, L. Boehlen, 1993, American heart journal.

Successful treatment of ischaemic ulceration of the skin in azotaemic hyperparathyroidism with parathyroidectomy.

P. Weidmann, A. Blumberg, 1977, British medical journal.

Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension

P. Weidmann, J. Colombo, H. Schiffl, 2004, European Journal of Clinical Pharmacology.

Effect on aging on plasma renin and aldosterone in normal man.

P. Weidmann, M. Maxwell, J. J. D. Lima, 1975, Kidney international.

[Radioisotope renography with subtraction of the extraparenchymal radioactivity].

P. Weidmann, C. Werning, W. Siegenthaler, 1972, Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Hypertension associated with tumors adjacent to renal arteries.

P. Weidmann, C. Werning, W. Siegenthaler, 1969, The American journal of medicine.

Plasma Renin Activity in Patients with Coarctation of the Aorta: A Comment on the Pathogenesis of Prestenotic Hypertension

P. Weidmann, C. Werning, W. Siegenthaler, 1969, Circulation.

[Increased renal prostaglandin E2 secretion in Bartter's syndrome].

F. Messerli, P. Weidmann, J. Flammer, 1977, Schweizerische medizinische Wochenschrift.

Autonomic function tests as related to age and gender in normal man

P. Weidmann, M. Gnädinger, B. Gautschy, 1986, Klinische Wochenschrift.

[Diagnostic procedure in arterial hypertension].

P. Weidmann, C. Werning, W. Siegenthaler, 1970, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis.

Effect of prostaglandin E1 on renin in the dog.

P. Weidmann, C. Werning, W. Siegenthaler, 1971, The American journal of physiology.

Mediastinal pseudocyst of the pancreas.

W. Rutishauser, P. Weidmann, W. Siegenthaler, 1969, The American journal of medicine.

Blood levels and renal effects of atrial natriuretic peptide in normal man.

P. Weidmann, F. Reubi, W. Rascher, 1986, The Journal of clinical investigation.

The renin-angiotensin-aldosterone system in terminal renal failure.

P. Weidmann, M. Maxwell, 1975, Kidney international. Supplement.

Hypovolemia contributes to the pathogenesis of orthostatic hypotension in patients with diabetes mellitus.

P. Weidmann, K. Laederach-Hofmann, P. Ferrari, 1999, The American journal of medicine.

Effects of slow ascent to 4559 M on fluid homeostasis.

P. Vock, P. Weidmann, D. Rennie, 1991, Aviation, space, and environmental medicine.

Atrial natriuretic factor in the Landry-Guillain-Barré syndrome.

P. Weidmann, M. Stäubli, P. Siegrist, 1988, The New England journal of medicine.

Radioimmunoassay for Type I Procollagen in Growth Hormone-deficient Children before and during Treatment with Growth Hormone

P. Weidmann, 1985 .

Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patiens on maintenance hemodialysis.

P. Weidmann, M. Dambacher, U. Hennes, 1980, Clinical nephrology.

[Treatment of therapy-resistant hypertension].

P. Weidmann, G. Keusch, 1977, Schweizerische medizinische Wochenschrift.

Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.

P. Weidmann, S. Shaw, A. Blumberg, 1988, The American journal of medicine.

Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension.

P. Weidmann, M. Bianchetti, C. Ferrier, 1987, Kidney international.

Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure.

P. Weidmann, P. Ferrari, A. Blumberg, 1992, Kidney international.

Long-Term Results of Percutaneous Transluminal Angioplasty for Renovascular Hypertension Using the Coaxial Catheter Technique in Patients With Atherosclerosis and Fibromuscular Dysplasia

P. Weidmann, P. Probst, F. Mahler, 1983 .

[Comparison of oral diazoxide and minoxidil in refractory hypertension].

P. Weidmann, F. Reubi, A. Meier, 1980, Klinische Wochenschrift.

[Percutaneous transluminal dilatation of renal artery stenosis: methods and results].

P. Weidmann, P. Probst, F. Mahler, 1982, VASA. Zeitschrift fur Gefasskrankheiten.

Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents.

T. Lüscher, G. Noll, P. Weidmann, 1996, Circulation.

Changes in renal function in essential hypertension.

J. Hodler, P. Weidmann, F. Reubi, 1978, The American journal of medicine.

Effect of sodium intake on plasma catecholamines in normal subjects.

V. Campese, S. Massry, P. Weidmann, 1979, The Journal of clinical endocrinology and metabolism.

Norepinephrine-related mechanism in hypertension accompanying renal failure.

P. Weidmann, D. Schohn, H. Jahn, 1985, Kidney international.

Metabolic effects of calcium antagonists in humans, with emphasis on carbohydrate, lipid, potassium, and uric acid homeostases.

P. Weidmann, B. Trost, 1988, Journal of cardiovascular pharmacology.

Antihypertensive Therapy in Diabetic Patients

P. Weidmann, B. Trost, C. Beretta‐Piccoli, 1985, Hypertension.

Potential pitfalls in the radioimmunoassay of physiological plasma levels of atrial natriuretic peptide.

P. Weidmann, S. Shaw, 1988, Zeitschrift für Kardiologie.

Alpha‐1‐adrenergic blockade and lipoprotein metabolism in essential hypertension

P. Weidmann, C. Ferrier, R. Mordasini, 1986, Clinical pharmacology and therapeutics.

Effects of diuretics alone or in combination with beta-adrenoceptor blockers on serum lipoproteins.

P. Weidmann, W. Riesen, H. Schiffl, 1982, British journal of clinical pharmacology.

[Diuretic treatment and serum lipoproteins: effects of tienilic acid and indapamide (author's transl)].

P. Weidmann, E. Peheim, R. Mordasini, 1982, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis.

[The effect of hydrochlorothiazide/amiloride alone or in combination with alpha-methyldopa on serum lipoproteins].

P. Weidmann, W. Riesen, H. Schiffl, 1981, Schweizerische medizinische Wochenschrift.

Atrial Natriuretic Factor, Renal Failure and Hemodialysis

P. Weidmann, S. Shaw, H. Saxenhofer, 1990, The International journal of artificial organs.

Studies on the mechanism of acute glucose-induced aldosterone suppression. Role of corticotrophin.

P. Weidmann, M. Bianchetti, C. Ferrier, 1983, Acta endocrinologica.

Dynamic studies of aldosterone in anephric man.

P. Weidmann, M. Maxwell, R. Horton, 1973, Kidney international.

Comparative Acute Effects of the Calcium Channel Blockers Tiapamil, Nisoldipine, and Nifedipine on Blood Pressure and Some Regulatory Factors in Normal and Hypertensive Subjects

P. Weidmann, K. Laederach, W. Ziegler, 1986, Journal of cardiovascular pharmacology.

Evaluation of autonomic neuropathy in diabetes mellitus

P. Weidmann, J. Flammer, W. Ziegler, 1979, Klinische Wochenschrift.

[The plasma renin activity in decompensated and non-decompensated diabetes insipidus. Simultaneously a contribution to the regulation of renin secretion].

P. Weidmann, C. Werning, W. Siegenthaler, 1969, Schweizerische medizinische Wochenschrift.

Disturbed noradrenergic blood pressure control in normotensive members of hypertensive families.

P. Weidmann, M. Bianchetti, C. Ferrier, 1984, British heart journal.

Plasma Renin Activity and Angiotensin Pressor Dose in Hypertension: Correlation and Diagnostic Implications

P. Weidmann, W. Siegenthaler, P. Endres, 1968, British medical journal.

Effects of Treatment with Diuretics on Serum Lipoproteins

P. Weidmann, A. Gerber, 1984, Journal of cardiovascular pharmacology.

Effect of acute and long-standing hypocalcemia on blood pressure and plasma renin activity in man.

S. Massry, P. Weidmann, M. Maxwell, 1974, The Journal of clinical endocrinology and metabolism.

Unaltered insulin sensitivity during calcium channel blockade with amlodipine

P. Weidmann, D. Giachino, W. Riesen, 2004, European Journal of Clinical Pharmacology.

Norepinephrine clearance and pressor effect in normal and hypertensive man

P. Weidmann, A. Meier, Z. Glück, 1980, Klinische Wochenschrift.

Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril

P. Weidmann, W. Riesen, Y. Allemann, 2004, European Journal of Clinical Pharmacology.

Correction of cardiovascular hypersensitivity to norepinephrine by potassium supplementation in normotensive members of hypertensive families and patients with essential hypertension.

P. Weidmann, M. Bianchetti, C. Ferrier, 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[Plasma renin activity in peripheral venous blood under various stimulation conditions].

P. Weidmann, C. Werning, W. Siegenthaler, 1969, Deutsche Medizinische Wochenschrift.

[On the diagnosis of renovascular hypertonia].

P. Weidmann, W. Siegenthaler, P. Endres, 1968, Deutsche medizinische Wochenschrift.

[Comparison of renin activity, angiotensin infusion test, separate urine studies according to Rapoport and isotope nephrogram in renal artery stenosis].

P. Weidmann, W. Siegenthaler, H. Rösler, 1967, Schweizerische medizinische Wochenschrift.

Reproducibility of insulin sensitivity measured by the minimal model method

P. Weidmann, W. Riesen, P. Ferrari, 1991, Diabetologia.

[The treatment of orthostatic hypotension with metoclopramide].

P. Weidmann, K. Laederach, 1991, Swiss medical weekly.

Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects.

P. Weidmann, W. Ziegler, A. Meier, 1982, Hypertension.

Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness.

W. Schobersberger, P. Weidmann, W. Rascher, 1991, Journal of applied physiology.

Nephropathy subsequent to hyperlipidemia.

J. Laissue, P. Weidmann, A. Teuscher, 2000, Clinical nephrology.

Rapidly progressive glomerulonephritis accompanying Legionnaires' disease.

P. Weidmann, F. Reubi, T. Hess, 1985, Archives of internal medicine.

Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension.

P. Weidmann, D. Hirsch, F. Reubi, 1977, The American journal of medicine.

[Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].

P. Weidmann, 1982, Swiss medical weekly.

Acute antihypertensive efficacy of channel blockade with lacidipine, a new dihydropyridine

P. Weidmann, M. Marcolli, C. Marone, 1991 .

Renin-angiotensin system in acute hypercalcemic hypertension in man.

P. Weidmann, C. Marone, 1986, American journal of nephrology.

Blood pressure control in normotensive members of hypertensive families.

P. Weidmann, M. Bianchetti, C. Ferrier, 1986, Kidney international.

Pathogenesis and treatment of hypertension in renal tuberculosis.

U. Studer, P. Weidmann, 1984, European urology.

Reduced plasma cyclic GMP but normal renal responses to atrial natriuretic factor in pre-hypertension.

P. Weidmann, P. Ferrari, A. Cozzio, 1996, Blood pressure.